Boston, MA -- (SBWIRE) -- 10/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: 1st NRG Corp. (OTCMKTS:FNRC), Hewlett-Packard Company (NYSE:HPQ), Dendreon Corporation (NASDAQ:DNDN), Arrowhead Research Corp (NASDAQ:ARWR).
1st NRG Corp. (OTCMKTS:FNRC) opened its shares at the price of $0.01for the day. Its closing price was $0.0023after losing -42.50% for the day. The company traded with the total volume of 40.07 million shares, while its average trading volume remained 3.84 million shares. The beta of FNRC stands at-23.42.
Will FNRC Get Buyers Even After The Recent Rally? Find Out Here
1st NRG Corp., an independent energy company, engages in the exploration, development, and production of natural gas properties in the United States.
Hewlett-Packard Company (NYSE:HPQ) percentage change surged2.12 % to close at $24.05 with the total traded volume of 16.36 million shares, and average volume of 16.44 million. The 52 week range of the stock remained $11.35 - $27.78, while its day lowest price was $23.49and it hit its day highest price at $24.39.
Will HPQ Continue To Move Higher? Find Out Here
Hewlett-Packard Company and its subsidiaries provide products, technologies, software, solutions, and services to individual consumers, small-and medium-sized businesses (SMBs), and large enterprises, including customers in the government, health, and education sectors worldwide.
Dendreon Corporation (NASDAQ:DNDN) started its trading session with the price of $2.40 and closed at $2.33 by scoring -2.92%. DNDN’s stocks traded with total volume of 4.26 million shares, while the average trading volume remained 4.28 million shares. The beta of DNDN stands at 4.13. Day range of the stock was $2.31 -$2.47.
Will DNDN Get Buyers Even After The Recent Rally? Find Out Here
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients.
Arrowhead Research Corp (NASDAQ:ARWR) ended its day with the loss of -9.72% and closed at the price of $7.99 after opening at $8.88. Stock traded during its last trading session with the total volume of 1.67 million shares, as compared to its average volume of 672,583 shares.
Will ARWR Get Buyers Even After The Recent Rally? Find Out Here
Arrowhead Research Corporation operates as a clinical stage therapeutics company. It has development programs in oncology, obesity, and chronic hepatitis B virus (HBV) infection.
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)